BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 7454962)

  • 21. [Methods of determination and theoretical principles of the serum protein binding of drugs (author's transl)].
    Scholtan W
    Arzneimittelforschung; 1978; 28(7):1037-47. PubMed ID: 385005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behaviour of uricemia in hyperlipoproteinemic subjects.
    Zdrenghea D; Marta D; Constantinescu M; Cucuianu M
    Med Interne; 1980; 18(4):385-90. PubMed ID: 7455583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial.
    Garg JP; Chasan-Taber S; Blair A; Plone M; Bommer J; Raggi P; Chertow GM
    Arthritis Rheum; 2005 Jan; 52(1):290-5. PubMed ID: 15641045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of significant urate binding to human serum proteins.
    Kovarsky J; Holmes EW; Kelley WN
    J Lab Clin Med; 1979 Jan; 93(1):85-91. PubMed ID: 759530
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypo-uricemia due to renal uricosuria (author's transl)].
    Dellas JA
    Sem Hop; 1980 Mar 8-15; 56(9-10):475-6. PubMed ID: 6244671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urate binding: a clue to the pathogenesis of gout.
    Bluestone R; Kippen I; Campion D; Klinenberg J; Whitehouse M
    J Rheumatol; 1974 Jun; 1(2):230-5. PubMed ID: 4457646
    [No Abstract]   [Full Text] [Related]  

  • 27. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
    Sturm G; Kollerits B; Neyer U; Ritz E; Kronenberg F;
    Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyperuricemia and gout: therapeutic indications].
    Pawlotsky Y
    Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of sex steroids in vivo and in vitro on the binding of uric acid to plasma proteins].
    Taddeo A; Renieri A; Fioravanti A; Morozzi G; Parrini E; D'Amato MS; Ricci MG
    Boll Soc Ital Biol Sper; 1984 Sep; 60(9):1709-14. PubMed ID: 6525290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The importance of ionic strength and protein concentration in the dialysis performance of autoanalyzer systems for the enzymatic determination of uric acid (author's transl)].
    Hunziker P; Keller H
    J Clin Chem Clin Biochem; 1978 Apr; 16(4):249-51. PubMed ID: 641453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uric acid: binding levels of urate ions in normal and uraemic plasma, and in human serum albumin.
    Farrell PC; Ward RA; Hone PW
    Biochem Pharmacol; 1975 Oct; 24(20):1885-7. PubMed ID: 1191338
    [No Abstract]   [Full Text] [Related]  

  • 33. [Determination of uric acid in blood. Experimental determination; critical studies of the technics and results].
    Cammeo F
    Quad Sclavo Diagn; 1971 Jun; 7(2):542-80. PubMed ID: 5152956
    [No Abstract]   [Full Text] [Related]  

  • 34. Inability of accumulated metabolic byproducts of uremia to alter the extent of warfarin binding in charcoal treated plasma.
    Bachmann K; Conway P; Shapiro R
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):117-30. PubMed ID: 663394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [When is hemofiltration indicated, in the treatment of renal insufficiency? (author's transl)].
    Pogglitsch H
    Acta Med Austriaca; 1980; 7(4-5):144-7. PubMed ID: 7246019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative biochemical studies in asymptomatic hyperuricemia and manifest gout with special reference to renal change].
    Beenken O; Kopperschläger G; Otto W; Häntzschel H; Pietruschka WD; Weinhold D
    Z Gesamte Inn Med; 1981 May; 36(9):294-8. PubMed ID: 7281841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study.
    Lin KC; Lin HY; Chou P
    J Rheumatol; 2000 Jun; 27(6):1501-5. PubMed ID: 10852278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease-specific noncompliance with drug treatment as a cause of persistent hyperuricemia and gout in anorexia nervosa.
    Gröbner W; Walter-Sack I; de Vries JX
    Eur J Med Res; 1998 Feb; 3(1-2):77-80. PubMed ID: 9512972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Urate transporter and renal hypouricemia].
    Enomoto A; Niwa T; Kanai Y; Endou H
    Rinsho Byori; 2003 Sep; 51(9):892-7. PubMed ID: 14560659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.